Correlation Between Tela Bio and Neuropace
Can any of the company-specific risk be diversified away by investing in both Tela Bio and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tela Bio and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tela Bio and Neuropace, you can compare the effects of market volatilities on Tela Bio and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tela Bio with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tela Bio and Neuropace.
Diversification Opportunities for Tela Bio and Neuropace
Average diversification
The 3 months correlation between Tela and Neuropace is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Tela Bio and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Tela Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tela Bio are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Tela Bio i.e., Tela Bio and Neuropace go up and down completely randomly.
Pair Corralation between Tela Bio and Neuropace
Given the investment horizon of 90 days Tela Bio is expected to under-perform the Neuropace. In addition to that, Tela Bio is 1.49 times more volatile than Neuropace. It trades about -0.21 of its total potential returns per unit of risk. Neuropace is currently generating about 0.07 per unit of volatility. If you would invest 1,087 in Neuropace on December 29, 2024 and sell it today you would earn a total of 151.00 from holding Neuropace or generate 13.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Tela Bio vs. Neuropace
Performance |
Timeline |
Tela Bio |
Neuropace |
Tela Bio and Neuropace Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tela Bio and Neuropace
The main advantage of trading using opposite Tela Bio and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tela Bio position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.Tela Bio vs. Sight Sciences | Tela Bio vs. Tactile Systems Technology | Tela Bio vs. Clearpoint Neuro | Tela Bio vs. CVRx Inc |
Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |